ARKG vs SPXU
ARK Genomic Revolution ETF vs ProShares UltraPro Short S&P500
ARKG—
ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense: —Yield: —
SPXU—
ProShares UltraPro Short S&P500
3x inverse daily performance of the S&P 500.
Expense: —Yield: —
Side-by-side metrics
| Metric | ARKG | SPXU |
|---|---|---|
Expense ratio Annual fee. Lower is better. | — | — |
Dividend yield Trailing 12-month yield. | — | — |
AUM Assets under management — bigger funds are typically more liquid. | — | — |
YTD return | — | — |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | — | — |
P/E ratio | — | — |
Last price | — | — |
Inception | — | — |
Issuer | ARK | ProShares |
ARKG top holdings
Holdings data unavailable for ARKG.
SPXU top holdings
Holdings data unavailable for SPXU.
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology.
About SPXU
SPXU (ProShares UltraPro Short S&P500) is 3x inverse daily performance of the S&P 500.